Table 1.

Patients' clinicopathological characteristics according to the levels of inflammation-related markers^a)

IL, interleukin; MCP-1, monocyte chemoattractant protein-1; ER, estrogen receptor; PR, progesterone receptor. ^a)Data are presented as number (%), ^b)Luminal A (ER⁺ and/or PR⁺, HER2^- and Ki-67 index<15%), luminal B ([ER⁺ and/or PR⁺, HER^-, and Ki-67 index≥15%] or [ER⁺ and/or PR⁺, and HER2⁺]), HER2 only (ER^-, PR^-, and HER2⁺), triple-negative (ER^-, PR^-, and HER2^-), ^c)The tumor grade was determined according to the Scarff-Bloom-Richardson classification modified by Elston and Ellis. ^*p<0.05.